A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01)
Patent
CA 2550217
Methods of inhibiting hyperglycemia-induced or free fatty acid-induced reactive oxygen formation in mammalian cells and mammals using the degradation product of glucagon-like peptide 1, GLP-1 (9-36) are provided. Various GLP-1 (9-36) compositions are also provided.
Cette invention concerne des méthodes propres à inhiber la formation d'oxygène réactif induite par hyperglycémie ou par a présence d'acides gras libres dans des cellules de mammifères et des mammifères utilisant le produit de dégradation du peptide 1, GLP-1 (9-36) de type glucacon. Sont également décrites diverses compositions de GLP-1 (9-36).
Albert Einstein College Of Medicine Of Yeshiva University
Osler Hoskin & Harcourt Llp
LandOfFree
Glp-1 (9-36) methods and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glp-1 (9-36) methods and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glp-1 (9-36) methods and compositions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1726694